IL85471A0 - Monoclonal antibodies to human pancreatic cancer,their production and hybridoma cell lines secreting them - Google Patents
Monoclonal antibodies to human pancreatic cancer,their production and hybridoma cell lines secreting themInfo
- Publication number
- IL85471A0 IL85471A0 IL85471A IL8547188A IL85471A0 IL 85471 A0 IL85471 A0 IL 85471A0 IL 85471 A IL85471 A IL 85471A IL 8547188 A IL8547188 A IL 8547188A IL 85471 A0 IL85471 A0 IL 85471A0
- Authority
- IL
- Israel
- Prior art keywords
- production
- cell lines
- monoclonal antibodies
- pancreatic cancer
- hybridoma cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
- A61K47/6859—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from liver or pancreas cancer cell
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/303—Liver or Pancreas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1655287A | 1987-02-19 | 1987-02-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL85471A0 true IL85471A0 (en) | 1988-07-31 |
Family
ID=21777714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL85471A IL85471A0 (en) | 1987-02-19 | 1988-02-19 | Monoclonal antibodies to human pancreatic cancer,their production and hybridoma cell lines secreting them |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0279669B1 (da) |
JP (1) | JP2792651B2 (da) |
CA (1) | CA1339709C (da) |
DE (1) | DE3854821T2 (da) |
DK (1) | DK175546B1 (da) |
IL (1) | IL85471A0 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5310874A (en) * | 1991-05-03 | 1994-05-10 | The Scripps Research Institute | Integrin α subunit cytoplasmic domain polypeptides and antibodies |
JPH05317082A (ja) * | 1991-08-06 | 1993-12-03 | Toray Ind Inc | モノクローナル抗体およびその用途 |
CA2441042A1 (en) * | 2001-03-15 | 2002-09-26 | International Bioimmune Systems, Inc. | Monoclonal antibody therapy for pancreas cancer |
ATE419533T1 (de) | 2002-10-31 | 2009-01-15 | Hoffmann La Roche | Verfahren/präparat zur erkennung von pankreaskrebs |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3329184A1 (de) * | 1983-08-12 | 1985-02-21 | Behringwerke Ag, 3550 Marburg | Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene |
GR850552B (da) * | 1984-03-07 | 1985-07-05 | Du Pont |
-
1988
- 1988-02-18 EP EP88301362A patent/EP0279669B1/en not_active Expired - Lifetime
- 1988-02-18 DE DE3854821T patent/DE3854821T2/de not_active Expired - Fee Related
- 1988-02-18 CA CA000559249A patent/CA1339709C/en not_active Expired - Fee Related
- 1988-02-19 IL IL85471A patent/IL85471A0/xx unknown
- 1988-02-19 JP JP63038443A patent/JP2792651B2/ja not_active Expired - Fee Related
- 1988-02-19 DK DK198800882A patent/DK175546B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPS63301899A (ja) | 1988-12-08 |
DK88288A (da) | 1988-08-20 |
CA1339709C (en) | 1998-03-10 |
EP0279669B1 (en) | 1995-12-27 |
DK175546B1 (da) | 2004-12-06 |
JP2792651B2 (ja) | 1998-09-03 |
DE3854821D1 (de) | 1996-02-08 |
EP0279669A2 (en) | 1988-08-24 |
DK88288D0 (da) | 1988-02-19 |
EP0279669A3 (en) | 1989-09-27 |
DE3854821T2 (de) | 1996-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL67721A (en) | Hybridoma cell lines,their preparation and their use for the production of human monoclonal antibodies | |
IL63354A (en) | Human hybridomas,their production and antibodies derived therefrom | |
IL79719A (en) | Pharmaceutical composition comprising monoclonal antibodies binding determinants of gram negative bacteria and hybridoma cell lines producing the antibodies | |
EP0119556A3 (en) | Monoclonal antibodies to human colon cancers and method | |
IL76247A0 (en) | Monoclonal antibodies to glycoconjugates,their production,their use and pharmaceutical compositions containing them,hybridoma cell lines secreting said antibodies and their preparation | |
IL88160A0 (en) | Cell lines and monoclonal antibodies | |
IL62965A0 (en) | Monoclonal antibodies to drugs and theri production | |
JPS57126424A (en) | Production of human monoclonal antibody by human hybridoma | |
DE3379406D1 (en) | Hybridoma cell lines and monoclonal antibodies to theophylline | |
EP0245993A3 (en) | Monoclonal antibodies against c5a and des-arg74-c5a, their production and use | |
EP0159025A3 (en) | Monoclonal antibody specific to human alpha2-plasmin | |
IL85471A0 (en) | Monoclonal antibodies to human pancreatic cancer,their production and hybridoma cell lines secreting them | |
GB8722020D0 (en) | Human anti-rh(d)monoclonal antibodies | |
EP0306680A3 (en) | Monoclonal antibodies to anti-thrombin binding substance, and their uses | |
EP0166458A3 (en) | Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells | |
GB8722019D0 (en) | Human anti-rh(d)monoclonal antibodies | |
GB8727030D0 (en) | Production of monoclonal antibodies | |
GB2176802B (en) | Monoclonal anti-human igg4 antibodies, their production and use | |
GB2207921B (en) | Monoclonal antibody to omega-gliadin and hybridoma thereof | |
IL75793A0 (en) | Monoclonal antibodies against human ifn-ypsilon,their preparation and their use and hybrid cell lines producing these antibodies | |
EP0295305A4 (en) | MONOCLONAL ANTIBODY, SPECIFIC TO TUMOR CELL SURFACE GANGLIOSIDE AND THE SAME-PRODUCING HYDRIDOM. | |
IL89857A0 (en) | Human monoclonal antibodies specifically recognizing rabies virus hybridoma,cells producing them,pharmaceutical compositions containing them and their production | |
IL78871A0 (en) | Monoclonal antibodies,hybridoma cell lines and their preparation | |
GB2145113B (en) | Production of human monoclonal antibodies | |
IL96488A0 (en) | Monoclonal antibodies,hybridoma cell lines and their preparation |